Absence of an interaction between iron and mycophenolate mofetil absorption

British Journal of Clinical Pharmacology

Volumn 62, Issue 4, 2006, Pages 492-495

  Ducray, Patricia Sanwald ^a   Banken, Ludger ^a   Gerber, Marianne ^b   Boutouyrie, Bruno ^a   Zandt, Hagen ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b Institut de Pharmacologie Clinique Roche   (France)

Author keywords

Absorption; Iron ion; Mycophenolate mofetil; Pharmacokinetics

Indexed keywords

FERROUS SULFATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; MALE; MOLECULAR MODEL; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ADULT; CROSS-OVER STUDIES; DRUG INTERACTIONS; FERROUS COMPOUNDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IRON; MALE; MYCOPHENOLIC ACID;

EID: 33748746308     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02541.x     Document Type: Article

References (6)

1. Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 1998; 34: 429-55.
2. Morii M, Ueno K, Ogawa A, Kato R, Yoshimura H, Wada K, Hashimoto H, Takada M, Tanaka K, Nakatani T, Shibakawa M. Impairment of mycophenolate mofetil absorption by iron ion. Clin Pharmacol Ther 2000; 68: 613-6.
3. Hale MD, Nicholls AJ, Bullingham RES, Hene R, Hoitsma A, Squifflet J-P, Weimar W, Vanrenterghem Y, Van de Woude FJ, Verpooten GA. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther 1998; 64: 672-83.
4. 2+. Metab Brain Dis 2003; 18: 1-9.
5. Mudge DW, Atcheson B, Taylor PJ, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Nicol DL, Pillans PI, Johnson DW. The effect of oral iron administration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial. Transplantation 2004; 77: 206-9.
6. Lorenz M, Wolzt M, Weigel G, Puttinger H, Horl WH, Fodinger M, Speiser W, Sunder-Plassmann G. Ferrous sulphate does not affect mycophenolic acid pharmacokinetics in kidney transplant patients. Am J Kidney Dis 2004; 43: 1098-103.